The Family Friendly Research Poster Session will be held on Saturday, June 29th from 6:30pm to 8:00pm at the 2019 Annual SMA Conference.
The Family Friendly Research Poster Session allows for one-on-one interactions between families and researchers. Cure SMA has invited researchers, who are attending SMA Researcher Meeting, to present family friendly research posters. During the event, families are encouraged to rotate to the different posters to ask questions and learn directly from the researchers involved in each of the projects being presented.
- Allison Ebert, PhD from the Medical College of Wisconsin: Understanding SMN function in Different Cell Types
- Allison Mazzella from Cure SMA: Assessing Clinical Meaningfulness and Patient Experience in the SMA Teen and Young Adult Populations
- Arthur Burghes, PhD & Anton Blatnik from the Ohio State University: Suppressors of SMN Function and Modifiers of Spinal Muscular Atrophy
- Janice Wong, MD & Kristina Johnson from Biogen: The Spinraza Clinical Development Program
- Garrett Ingrando, MBA from Biogen: SPINRAZA Experience in the Real World
- Brunhilde Wirth, PhD from the University of Cologne, Germany: Genetic modifiers of SMA Help Some People to Remain Asymptomatic; How Can This Knowledge Help All People with SMA?
- Cera Hassinan from Johns Hopkins School of Medicine: Neurofilament as a biomarker for SMA
- Chad Heatwole, MD, MS-CI from University of Rochester Medical Center: Measurement of a Patient’s Health Status (The SMA-Health Index)
- Geneviève Paris & Andréanne Didillon from the University of Ottawa: SMN and friends: What we can learn from SMN Interactors
- Jen Szegda & Erin Treece, MS from Scholar Rock: SMA Muscle-Directed Therapy Advancing in Clinical Development.
- Hannah Staunton & Samuel Ewing, EngD from F. Hoffmann-La Roche: New measures of function and independence in Spinal Muscular Atrophy
- Jamie Shish from Cure SMA: Cure SMA Newborn Screening Survey and Database
- Reid Garner, Christiano R Alves, PhD, Kathryn J Swoboda, MD from Massachusetts General Hospital & Harvard Medical School: Circulating biomarkers for Spinal Muscular Atrophy
- Senam Beckley-Kartey, Marco Castillo, MD & Fani Petridis from F. Hoffmann-La Roche: Roche and Genentech Spinal Muscular Atrophy Clinical Development Program
- Kevin Kaifer, PhD from the University of Missouri: Astrocytes Contribute to Motor Neuron Degeneration in Spinal Muscular Atrophy
- Zaida Alipio-Gloria, Arnab K. Chatterjee, Jingxin Wang, Andrew To, Kristen Johnson from Calibr, a Division of Scripps Research: Innovative Screening Approaches to Identify the Next Generation of SMN-Inducing Compounds
- Frank Bennet, PhD & Kristina Bowyer from Ionis Pharmaceuticals: Antisense Oligonucleotide Strategies for SMA
- Krysta Engel, PhD from the University of Colorado: Transcriptome-Wide Interrogation of SMN-mediated RNA Localization Mechanisms in Neurons
- Laxman Gangwani, PhD from Texas Tech University: Overview and Comparison of SMN-Dependent and SMN-Independent Methods for the Treatment of Spinal Muscular Atrophy
- Lisa Belter from Cure SMA: Cure SMA Membership: Findings from the 2019 Membership Survey
- Samantha Edell, Darren T. Hwee, PhD, Stacy Rudnicki, MD, Bettina Cockroft, MD, MBA, Andrew Wolff, MD & Lucie Vu, PharD from Cytokinetics: Results from Two Pre-clinical Studies: Reldesemtiv in Combination with Nusinersen and in Combination with SMN-C1 Shows Improved Muscle Function in Mouse Model of Spinal Muscular Atrophy
- Mary Schroth, MD, Jamie Shish, Teresa Stewart & Abigail Paras from Cure SMA: Cure SMA Clinical Care Center Network and SMA Clinical Data Registry
- Doug Sproule, MD from AveXis: Provide an overview of ZOLGENSMA indication, efficacy, safety and dosing for Caregivers
- Kathy L. Poulin, Joshua Del Papa, Hugh J. McMillan, MD, Jodi Warman Chardon, MD, Rashmi Kothary,PhD & Robin J. Parks, PhD from the Ottawa Hospital Research Institute: Biomarkers for Spinal Muscular Atrophy
- Samuel R. Rosenfeld, MD from Children’s Hospital of Orange County: 20 Year Experience with Segmental Sublaminar Instrumentation for Guided Growth in Early Onset Scoliosis
- Bakri Elsheikh, MD & Sarah Heintzman, RN from the Ohio State University: The Spinraza Treatment Initiative at The Ohio State University
- Saravanan Arumugam, Michael Kahl, Zhaofa Xu & Yongchao Ma, PhD from Northwestern Unviersity: Targeting Mitochondria, the Powerhouse in Motor Neurons, for Treating SMA
- Fernanda Boulos, PhD and Svetlana Jevtic, DVM, Msc from Novartis: Branaplam (LMI070) clinical program summary
- Sibylle Jablonka, PhD & Utz Fischer, PhD from the University of Wuerzburg, Germany: Calcium Channels in SMA: What about the SMN complex?
- Erin Kelly from Cure SMA: The SMA Patient and Family Voice: Impacting our Community and Stakeholders Through Advocacy, Clinical Care, Research, and Industry Partnerships
- Josh Noone, PhD, Sarah Whitmire, MS, Daniel Buchenberger, MS, Rosalina Mills, Christine Pozniak, PhD & Er Chen, MPP from F. Hoffmann-La Roche: Impact of SMA on Caregivers’ Daily Activities and Health-Related Quality of Life